GH Research (GHRS) Stock Forecast, Price Target & Predictions
GHRS Stock Forecast
GH Research stock forecast is as follows: an average price target of $31.00 (represents a 282.72% upside from GHRS’s last price of $8.10) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
GHRS Price Target
The average price target for GH Research (GHRS) is $31.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $31.00 to $31.00. This represents a potential 282.72% upside from GHRS's last price of $8.10.
GHRS Analyst Ratings
According to 2 Wall Street analysts, GH Research's rating consensus is 'Buy'. The analyst rating breakdown for GHRS stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
GH Research Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 06, 2024 | Sumant Kilkami | Canaccord Genuity | $31.00 | $11.68 | 165.41% | 282.72% |
The latest GH Research stock forecast, released on May 06, 2024 by Sumant Kilkami from Canaccord Genuity, set a price target of $31.00, which represents a 165.41% increase from the stock price at the time of the forecast ($11.68), and a 282.72% increase from GHRS last price ($8.10).
GH Research Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $31.00 |
| Last Closing Price | $8.10 | $8.10 | $8.10 |
| Upside/Downside | -100.00% | -100.00% | 282.72% |
In the current month, the average price target of GH Research stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to GH Research's last price of $8.10. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 06, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| May 06, 2024 | Canaccord Genuity | Buy | Buy | Hold |
GH Research's last stock rating was published by H.C. Wainwright on Sep 06, 2024. The company gave GHRS a "Buy" rating, the same as its previous rate.
GH Research Financial Forecast
GH Research Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - | $80.00K |
| High Forecast | - | - | - | - | - | - | - | $80.00K |
| Low Forecast | - | - | - | - | - | - | - | $80.00K |
| # Analysts | - | - | - | - | - | - | - | 3 |
| Surprise % | - | - | - | - | - | - | - | - |
GH Research's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. GHRS's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
GH Research EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | 3 |
| EBITDA | - | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - |
undefined analysts predict GHRS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than GH Research's previous annual EBITDA (undefined) of $NaN.
GH Research Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | 3 |
| Net Income | - | - | - | - | - | - | - | - |
| Avg Forecast | $-10.93M | $-11.45M | $-11.45M | $-10.93M | $-12.38M | $-12.80M | $-11.45M | $-11.45M |
| High Forecast | $-10.93M | $-11.45M | $-11.45M | $-10.93M | $-12.38M | $-10.43M | $-11.45M | $-11.45M |
| Low Forecast | $-10.93M | $-11.45M | $-11.45M | $-10.93M | $-12.38M | $-14.22M | $-11.45M | $-11.45M |
| Surprise % | - | - | - | - | - | - | - | - |
GH Research's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. GHRS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
GH Research SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | 3 |
| SG&A | - | - | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - |
GH Research's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to GHRS last annual SG&A of $NaN (undefined).
GH Research EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | 3 |
| EPS | - | - | - | - | - | - | - | - |
| Avg Forecast | $-0.21 | $-0.22 | $-0.22 | $-0.21 | $-0.24 | $-0.25 | $-0.22 | $-0.22 |
| High Forecast | $-0.21 | $-0.22 | $-0.22 | $-0.21 | $-0.24 | $-0.20 | $-0.22 | $-0.22 |
| Low Forecast | $-0.21 | $-0.22 | $-0.22 | $-0.21 | $-0.24 | $-0.27 | $-0.22 | $-0.22 |
| Surprise % | - | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, GH Research's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to GHRS previous annual EPS of $NaN (undefined).
GH Research Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals | $1.50 | $24.75 | 1550.00% | Buy |
| MOLN | Molecular Partners | $5.08 | $29.00 | 470.87% | Buy |
| HOWL | Werewolf Therapeutics | $2.23 | $12.00 | 438.12% | Buy |
| GHRS | GH Research | $8.10 | $31.00 | 282.72% | Buy |
| PEPG | PepGen | $9.12 | $29.50 | 223.46% | Buy |
| ANEB | Anebulo Pharmaceuticals | $2.27 | $6.00 | 164.32% | Buy |
| RZLT | Rezolute | $4.99 | $13.00 | 160.52% | Buy |
| RLAY | Relay Therapeutics | $7.60 | $19.40 | 155.26% | Buy |
| MLYS | Mineralys Therapeutics | $11.98 | $30.00 | 150.42% | Buy |
| GPCR | Structure Therapeutics | $38.44 | $86.00 | 123.73% | Buy |
| STOK | Stoke Therapeutics | $15.12 | $33.75 | 123.21% | Buy |
| RCUS | Arcus Biosciences | $16.73 | $35.20 | 110.40% | Buy |
| ANNX | Annexon | $6.99 | $14.00 | 100.29% | Buy |
| PHVS | Pharvaris | $20.25 | $38.50 | 90.12% | Buy |
| CGEM | Cullinan Oncology | $17.24 | $32.00 | 85.61% | Buy |
| DSGN | Design Therapeutics | $5.77 | $9.67 | 67.59% | Buy |
| ELYM | Eliem Therapeutics | $7.96 | $13.00 | 63.32% | Buy |
| JANX | Janux Therapeutics | $49.46 | $59.25 | 19.79% | Buy |
| IKNA | Ikena Oncology | $1.67 | $1.33 | -20.36% | Buy |
| CYT | Cyteir Therapeutics | $3.02 | $2.00 | -33.77% | Sell |
GHRS Forecast FAQ
Is GH Research a good buy?
Yes, according to 2 Wall Street analysts, GH Research (GHRS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of GHRS's total ratings.
What is GHRS's price target?
GH Research (GHRS) average price target is $31 with a range of $31 to $31, implying a 282.72% from its last price of $8.1. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will GH Research stock go up soon?
According to Wall Street analysts' prediction for GHRS stock, the company can go up by 282.72% (from the last price of $8.1 to the average price target of $31), up by 282.72% based on the highest stock price target, and up by 282.72% based on the lowest stock price target.
Can GH Research stock reach $12?
GHRS's average twelve months analyst stock price target of $31 supports the claim that GH Research can reach $12 in the near future.
What are GH Research's analysts' financial forecasts?
GH Research's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $80K (high $80K, low $80K), average EBITDA is $0 (high $0, low $0), average net income is $-48.074M (high $-45.704M, low $-49.496M), average SG&A $0 (high $0, low $0), and average EPS is $-0.924 (high $-0.878, low $-0.951). GHRS's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-44.744M (high $-44.744M, low $-44.744M), average SG&A $0 (high $0, low $0), and average EPS is $-0.86 (high $-0.86, low $-0.86).